AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2011
May 16, 2011
30583_dirs_2011-05-16_dbc0539f-dbcc-4dfa-852e-a34b782ee5f1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2011-05-12
Reporting Person: Davis George Eric (SVP, General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-05-12 | Common Stock | A | 8500 | — | Acquired | 36401 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-05-12 | Stock Option (right to buy) | $26.49 | A | 65000 | Acquired | 2021-05-11 | Common Stock (63000) | Direct |
Footnotes
F1: Restricted stock units granted on May 12, 2011. Price not applicable.
F2: Options vest 6/48ths on November 12, 2011 and 1/48th on the 12th of each month thereafter.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19